<qa>  What is the Phase II Phase II?This study is divided into 2 phases conducted in sequence for a total of 6 visits: Phase I ScreeningEligibility which includes a Screening Visit, followed by 2 Eligibility Visits E1 and E2 and Phase II TreatmentFollow-up which includes 3 visits at Week 2, Week 6, and Month 3. Following washout of any IOP-lowering medication, subjects who meet all inclusionexclusion criteria at both Eligibility visits and had IOP measurements within the specified range during this period will be randomized to Phase II. 